At a recent Board of Directors meeting, Mr. Boyd Evans was welcomed as our Company’s new Chief Financial Officer. The timing of Mr. Evans’ appointment coincides with the anticipation of increased production requirements and expansion into new markets as regulatory approval efforts move forward not only in the U.S. but Chile, Peru, Columbia and Brazil. In the U.S., we have experienced increasing levels of interest from both the private and government hospital sectors since announcing our Generation III AsepticSure System. The Company is currently more optimistic about the prospects for commercial success than at any other time in its recent history, making Mr. Evans’ experience both timely and appropriate as he takes up his new role.
Mr. Evans has 15 years of experience as a highly skilled finance leader. His experience spans expertise in financial accounting and systems management in rapidly growing and complex environments. He brings a strong background in managing operations and finance together with system analysis and implementations. Mr. Evans also has an understanding of business cycles and financial operations from purchasing through manufacturing and sales, as well as strategic planning, budgeting, forecasting, contract proposals, government contract regulations, and reporting.
Mr. Evans most recently served as Vice President of Finance and Business Systems for BioFire Defense, a company in the medical diagnostics arena. He directed the operational functions of Finance and the IT teams during an acquisition by bioMerieux, SA, a company operating in over 150 countries with annual revenues of €1.965 billion in 2015.
Mr. Evans’ experience is clearly a fit Medizone is pleased to bring onto our team. Boyd is a Certified Public Accountant, with a BA in Information Systems, a BS in Accounting and an MBA from the University of Utah.
Welcome aboard Boyd!
Edwin G. Marshall
Chairman of the Board
Chief Executive Officer